We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Improving Substance Abuse Treatment Aftercare Adherence and Outcome

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00057187
First Posted: March 31, 2003
Last Update Posted: April 7, 2015
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
Virginia Polytechnic Institute and State University
Duke University
Information provided by (Responsible Party):
VA Office of Research and Development
  Purpose
Although substance abuse treatment continuing care participation is strongly related to positive treatment outcomes, participation rates are low and few interventions have been developed that improve continuing care adherence and outcome.

Condition Intervention
Substance Dependence Compliance Treatment Outcome Behavioral: Contracting, Prompting and Reinforcing

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Improving Substance Abuse Treatment Aftercare Adherence and Outcome

Further study details as provided by VA Office of Research and Development:

Estimated Enrollment: 157
Study Completion Date: January 2005
Arms Assigned Interventions
Arm 1 Behavioral: Contracting, Prompting and Reinforcing

Detailed Description:

Background:

Although substance abuse treatment continuing care participation is strongly related to positive treatment outcomes, participation rates are low and few interventions have been developed that improve continuing care adherence and outcome.

Objectives:

The objectives of the study were: 1) to compare the effectiveness of an aftercare intervention consisting of a participation contract, attendance prompts, and attendance reinforcers (CPR) to a standard treatment (STX) on adherence to therapy; and 2) to assess the effects of this intervention on treatment outcome

Methods:

We recruited 150 veterans from the Salem VAMC�s SARRTP who could participate in aftercare. Our population is similar to those in other VA�s (97% male, 54% Caucasian, 46% minority, 49 years mean age, 44% alcohol dependent only, 56% drug dependent, and 44% with a dual diagnosis). In this randomized clinical trial, treatment adherence and outcome were measured at baseline and 3-, 6- and 12-months after participants entered treatment using interviews, questionnaires, alcohol and drug screens, VA medical records, and therapist ratings. The study design is a repeated measures nested cohort design, with an intervention and a standard care group. The primary outcome, abstinence rate, will be analyzed using a logistic regression model in which the parameters of interest are estimated using Generalized Estimating Equations (GEE).

Status:

Participant recruitment and follow-up interviews were completed in June 2003 and August 2004, respectively. The HSR&D final report was submitted in April 2005. The main results paper and additional papers will be submitted for publication in 2005.

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

All graduates of the Salem VA's SARRTP who: live within a 60 minute drive of the Salem VAMC, or 1 of our 5 SARRTP outreach clinics; have transportation and a job schedule that allows them to attend outpatient aftercare therapy.

Exclusion Criteria:

  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00057187


Locations
United States, Virginia
Salem VA Medical Center, Salem, VA
Salem, Virginia, United States, 24153
Sponsors and Collaborators
VA Office of Research and Development
Virginia Polytechnic Institute and State University
Duke University
Investigators
Principal Investigator: Steven J Lash, PhD Salem VA Medical Center, Salem, VA
  More Information

Publications:
Responsible Party: VA Office of Research and Development
ClinicalTrials.gov Identifier: NCT00057187     History of Changes
Other Study ID Numbers: IIR 99-282
First Submitted: March 27, 2003
First Posted: March 31, 2003
Last Update Posted: April 7, 2015
Last Verified: February 2007

Additional relevant MeSH terms:
Substance-Related Disorders
Chemically-Induced Disorders
Mental Disorders


To Top